CSIMarket
 


Syros Pharmaceuticals Inc   (NASDAQ: SYRS)
Other Ticker:  
 

Syros Pharmaceuticals Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

 


What is ROE for Syros Pharmaceuticals Inc in the third quarter 2024?
Syros Pharmaceuticals Inc recorded a cumulative net loss of $-98 million during 12 months ending in the third quarter 2024, resulting in a negative return on equity (ROE) of -2746.84%.

Within the Major Pharmaceutical Preparations industry 380 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2024 from 3673 to 3824.

What is ROE?



Return On Equity (Sep 30 2024)
III. Quarter
(Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
Y / Y Equity Change - - -85.9 % -86.96 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -98 -132 -144 -165 -105
Return On Equity (TTM) -2746.84 % -853.34 % -409.15 % -282.58 % -122.04 %
SYRS's Total Ranking # 3824 # 3673 # 0 # 0 # 3604
Equity (TTM) in Millions -11 -6 15 17 36
Seq. Equity Change - - -9.63 % -54.1 % -50.43 %
Seq. Net Income Change - - - - -

Return On Equity Company Ranking
Within: No.
Industry # 381
Sector # 796
Overall # 3824

Return On Equity Statistics
High Average Low
-63.8 %
-232.2 %
-2746.84 %
(Sep 30 2018)   (Sep 30 2024)





SYRS Annual Return On Equity (Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2019)
2019
Total Equity in Millions 17 128 85 91 79
Y / Y Equity Change -86.96 % 49.89 % -5.89 % 14.36 % 0.76 %
Net Income in Millions -165 -95 -87 -84 -75
Y / Y Net Income Change - - - - -
Return On Equity -987.72 % -74.1 % -101.57 % -92.81 % -95.27 %





More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
SYRS's' Return on Equity at Yahoo Finance
SYRS's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Roe for SYRS's Competitors
Return On Equity for Syros Pharmaceuticals Inc 's Suppliers
Roe for SYRS's Customers




Companies with similar Return On Equity at Sep 30 2024, within Healthcare Sector ROE


Date modified: 2024-12-29T19:28:16+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com